SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHD.L Regulatory News (PHD)

  • There is currently no data for PHD

First bePayd contract

9 Dec 2020 07:00

RNS Number : 9905H
PROACTIS Holdings PLC
09 December 2020
 

Proactis Holdings PLC

 

First bePayd contract

 

Proactis Holdings PLC, the business spend management solution provider, is pleased to announce that it has signed its first contract for the provision of bePayd, its accelerated payment service, with Experbuy, a French company offering a business process outsourcing solution that enables companies to manage their tail spend purchases more effectively.

 

Experbuy is a subsidiary of EPSA, a group with international operations helping organisations increase performance and profitability through three major areas of expertise: support with purchasing, organisation, performance and change management issues; cost control through the optimisation of tax, social security and occupational accidents; and the marketplace (which Experbuy forms part of).

 

This contract enables Experbuy to deploy bePayd for use by its own suppliers which aggregate to approximately €180m of annual spend across 65,000 suppliers.

 

bePayd allows suppliers to accelerate the payment of an approved invoice in return for a small discount and is primarily aimed at the long tail of small suppliers in the supply chain, a population that is currently underserved. bePayd is market-leading in its simplicity, speed and convenience without any detriment to security or risk and is entirely flexible down to single invoice level with extremely low values because of the end-to-end automation of the process. Funding of the early settlement can be provided by the customer (as is the case with Experbuy), Proactis (through a dedicated facility with HSBC) or a blended model.

 

Tim Sykes, Proactis CEO, commented:

"I am delighted to have signed our first bePayd contract with Experbuy, part of the EPSA Group. We look forward to working with Experbuy to drive take-up of this great service to suppliers over the coming months and beyond. As we look forwards, the solution has never seemed more relevant, and with a healthy pipeline of opportunities, we are optimistic about its prospects in 2021."

 

For further information, please contact:

 

Proactis Holdings PLC

01937 545070 x1115

Tim Sykes, Chief Executive Officer

Richard Hughes, Chief Financial Officer

 

 

investorcontact@proactis.com

finnCap Ltd

Carl Holmes/Emily Watts/Matthew Radley - Corporate Finance

Andrew Burdis/Richard Chambers - ECM

 

 

 

0207 220 0500

 

Alma PR

Rebecca Sanders-Hewett/Sam Modlin/David Ison

 

020 3405 0205

proactis@almapr.co.uk

Notes to Editors:

 

Proactis creates, sells and maintains software and services which enable organisations to streamline, control and monitor all indirect expenditure. Its solutions are used in approximately 1,100 buying organisations around the world from the commercial, public and not-for-profit sectors. 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUPGMCPUPUGBR
Date   Source Headline
29th Apr 20217:00 amRNSInterim Results
23rd Mar 20217:00 amRNSContract Win
24th Feb 20217:01 amRNSTrading Update & Notice of Results
24th Feb 20217:00 amRNSbePayd Strategic Contract Win
10th Feb 20217:00 amRNSStrategic Contract Win
8th Jan 202111:15 amRNSHolding(s) in Company
17th Dec 20208:58 amRNSDirector/PDMR Shareholding
14th Dec 20205:19 pmRNSResult of AGM
9th Dec 20207:00 amRNSFirst bePayd contract
7th Dec 20205:00 pmRNSHolding(s) in Company
2nd Dec 20207:00 amRNSNotice of AGM
2nd Dec 20207:00 amRNSDirectorate Change
30th Nov 20207:00 amRNSStrategic Contract Win
19th Nov 20207:00 amRNSDirector/PDMR Shareholding
10th Nov 20205:21 pmRNSHolding(s) in Company
3rd Nov 20205:09 pmRNSHolding(s) in Company
29th Oct 202011:40 amRNSDirector/PDMR Shareholding
29th Oct 20207:00 amRNSFinal Results
19th Oct 20207:00 amRNSStrategic Contract Win
14th Oct 20207:00 amRNSNotice of Results
6th Oct 20205:02 pmRNSHolding(s) in Company
6th Oct 20207:00 amRNSDirectorate Change
1st Oct 20207:00 amRNSDirectorate Change
2nd Sep 20205:07 pmRNSHolding(s) in Company
25th Aug 20207:00 amRNSTrading Update
13th Jul 20205:04 pmRNSHolding(s) in Company
24th Jun 20207:00 amRNSHolding(s) in Company
16th Jun 20206:16 pmRNSHolding(s) in Company
28th May 20208:27 amRNSHolding(s) in Company
27th May 20205:09 pmRNSHolding(s) in Company
22nd May 20207:00 amRNSPerformance Update
21st May 202011:50 amRNSHolding(s) in Company
12th May 20204:40 pmRNSSecond Price Monitoring Extn
12th May 20204:35 pmRNSPrice Monitoring Extension
7th May 20207:00 amRNSHolding(s) in Company
6th May 20205:53 pmEQSForm 8.3 - Proactis Holdings Plc
6th May 20203:42 pmEQSForm 8.3 - Proactis Holdings Plc
6th May 202011:00 amRNSPrice Monitoring Extension
30th Apr 20201:35 pmRNSDirector/PDMR Shareholding
29th Apr 20207:00 amRNSInterim Results
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:35 pmRNSPrice Monitoring Extension
28th Apr 20209:05 amRNSSecond Price Monitoring Extn
28th Apr 20209:00 amRNSPrice Monitoring Extension
28th Apr 20207:00 amRNSReset of bank facilities
20th Apr 20207:00 amRNSCOVID-19 Update & Notice of Results
8th Apr 202010:57 amRNSHolding(s) in Company
7th Apr 20204:41 pmRNSSecond Price Monitoring Extn
7th Apr 20204:35 pmRNSPrice Monitoring Extension
17th Mar 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.